Peptide Therapy Side Effects: What to Expect and When to Worry

Peptides Are Not Side-Effect Free

The peptide therapy space has a marketing problem: everything sounds miraculous and consequence-free. "Natural." "Bioidentical." "Your body already makes these." While some of that framing is technically accurate, it creates an impression that peptide therapy carries no risk.

That is not true. Peptides are biologically active molecules. They produce effects — intended and unintended. You deserve to know what to expect before starting.

Universal Side Effects (Most Peptides)

Injection Site Reactions

The most common side effect across all injectable peptides:

• Redness, itching, or mild swelling at the injection site
• Small bruises
• Temporary burning or stinging during injection

These are typically mild and self-limiting. They reflect the injection process more than the peptide itself. Rotating injection sites minimizes accumulation of local irritation.

Water Retention

Many peptides that stimulate growth hormone release cause mild fluid retention:

• Slightly puffy fingers or face in the morning
• Mild increase in blood pressure (usually 5-10 mmHg)
• Temporary weight gain (1-3 pounds of water, not fat)

This usually stabilizes within 2-4 weeks. If significant edema develops, dose reduction is warranted.

Headaches

Common in the first 1-2 weeks of therapy, particularly with growth hormone-releasing peptides. Usually resolve as the body adjusts. Adequate hydration helps.

Growth Hormone Peptides (Sermorelin, Ipamorelin, CJC-1295, Tesamorelin)

Common Side Effects

• Flushing — warmth and redness of the face and chest, especially with GHRH analogs. Usually brief (minutes).
• Drowsiness — particularly when dosed at bedtime (which is recommended). Most patients find this beneficial rather than problematic.
• Increased hunger — GH-releasing peptides (especially ghrelin mimetics like ipamorelin and MK-677) can increase appetite. This is a feature for some patients and a bug for others.
• Joint stiffness — from increased GH/IGF-1. Mild stiffness, particularly in hands and wrists. Usually dose-dependent.
• Numbness/tingling in extremities — carpal tunnel-like symptoms from fluid retention and tissue growth around nerves.

Less Common but Important

• Blood sugar changes — growth hormone is counter-regulatory to insulin. Prolonged use can increase fasting glucose and insulin resistance. Monitor fasting glucose and HbA1c.
• Potential tumor growth — theoretical concern. GH and IGF-1 promote cell growth. Patients with active cancer or strong family history should discuss this risk carefully.

MK-677 (Ibutamoren) Specific

• More pronounced hunger (ghrelin receptor activation)
• Water retention tends to be greater than injectable peptides
• Potential for elevated prolactin
• Long-term insulin resistance concern (more than other GH peptides)

BPC-157 and TB-500 (Healing Peptides)

BPC-157 Side Effects

BPC-157 has a favorable safety profile in available data:

• Nausea (uncommon, usually at higher doses)
• Dizziness (rare)
• Headache (rare)
• Theoretical concern: angiogenesis promotion could theoretically support tumor growth in active cancer (not demonstrated, but biologically plausible)

TB-500 (Thymosin Beta-4) Side Effects

• Head rush or lightheadedness after injection
• Fatigue (first few days)
• Theoretical concern: similar to BPC-157, promotes tissue growth including potential tumor growth

PT-141 (Bremelanotide — Sexual Function)

• Nausea — the most common and often dose-limiting side effect. Can be significant. Starts 30-60 minutes after injection.
• Flushing — facial and body flushing
• Headache — common
• Elevated blood pressure — transient, usually mild
• Darkening of skin — melanocyte stimulation can cause hyperpigmentation (moles may darken, skin may tan). Usually reversible.

PT-141 should not be used more than 8 times per month per FDA labeling for the nasal spray version (Vyleesi). Excessive use may increase blood pressure and skin pigmentation risk.

Melanotan II (Tanning Peptide)

• Nausea — common, especially initially
• Facial flushing
• Darkening of existing moles — requires monitoring. Any mole that changes shape, border, or becomes asymmetric needs evaluation.
• Spontaneous erections (in men)
• Appetite suppression
• New nevi (moles) — concerning and requires dermatologic monitoring
• Potential melanoma risk — theoretical and debated, but the mechanism (melanocyte stimulation) warrants extreme caution

I am cautious about Melanotan II specifically because of the melanoma concern.

When to Stop and Call Your Provider

Discontinue peptide therapy and contact your provider if:

• Persistent swelling in hands, feet, or face that does not resolve
• Severe headache or visual changes
• Significant blood pressure elevation (above 150/90)
• New or changing moles (for melanocyte-stimulating peptides)
• Joint pain that limits function (not just mild stiffness)
• Fasting glucose consistently above 110 mg/dL (for GH peptides)
• Chest pain or palpitations
• Signs of allergic reaction (difficulty breathing, hives, facial swelling)

Monitoring While on Peptide Therapy

Appropriate lab monitoring depends on the peptide:

Growth Hormone Peptides

• IGF-1 levels (every 3-6 months) — should be in upper-normal range, not supraphysiologic
• Fasting glucose and HbA1c (every 3-6 months)
• Comprehensive metabolic panel
• Lipid panel

All Peptides

• Baseline labs before starting
• Follow-up at 6-8 weeks to assess response and side effects
• Periodic reassessment of goals and continued appropriateness

The Quality Problem

Perhaps the biggest "side effect" risk in peptide therapy is not the peptides themselves — it is getting contaminated or misdosed product. The peptide market includes:

• Compounding pharmacies (regulated, tested)
• Research chemical suppliers (unregulated, variable quality)
• International sources (no quality guarantee)

Always obtain peptides through a licensed compounding pharmacy with third-party testing. The side effects of a contaminated peptide are unpredictable and potentially dangerous.

The Bottom Line

Peptide therapy is generally well-tolerated when prescribed appropriately, dosed correctly, and monitored. But "generally well-tolerated" is not "side-effect free." Know what to expect, know what to report, and work with a provider who monitors your response.

At Coral, we prescribe peptide therapy with proper baseline labs, clear monitoring protocols, and ongoing support. [Start your visit](/start) if you want peptide therapy done right.